Eleven outstanding early career researchers from around the world will join the University of Sydney in 2017 under the University of Sydney Fellowship scheme.
Now in its 21st year, Sydney Fellows was the first scheme of its kind in Australia when launched in 1996. It aims to recruit promising young scholars in order to enhance the research strengths and culture of the University and enable them to contribute to its thriving intellectual life.
This year, the scheme focused on recruiting talented recent doctoral graduates who can contribute to our whole-of-university multidisciplinary initiatives, including the Charles Perkins Centre, the Brain and Mind Centre and the China Studies Centre.
Canadian neuroscientist Dr Kaylena Ehgoetz Martens is among the 2017 fellows. Working with the Brain and Mind Centre, she will investigate whether walking behaviour and associated brain network changes in high-risk individuals can act as an early biomarker for Parkinson’s disease.
Banglideshi researcher Dr Mohammad Ali Moni will join the Cancer Research Network to develop machine-learning techniques to diagnose and predict the prognosis of ovarian cancer patients, while British physicist Dr Benjamin Brown will join the Australian Institute for Nanoscale Science and Technology to help bring practical quantum technologies closer to reality.
Project: 'Functional genomics of Cryptococcus gattii elucidates, new niche adaptations and the emergence of novel clinical phenotypes'
The NHMRC has funded an alliance of Aboriginal and Torres Strait Islander leaders, health services, clinicians and researchers across Australia to develop a suite of workforce development, prevention and treatment programs.
Dr Michael Bowen has won a Eureka Prize for Outstanding Early Career Researcher – the third time in a row Sydney has won this category in the Oscars of Australian science – in recognition of his research that focuses on oxytocin and serious brain disorders.
The University of Sydney is among four universities to share in the NHMRC Program Grant to help reduce unnecessary health testing and treatment.